#BGBl. 2025 I Nr. 236Twenty-Third Regulation Amending the Medicinal Products Prescription Regulation
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This regulation, published in the German Federal Law Gazette (BGBl. I Nr. 236) on 13 October 2025, amends the Arzneimittelverschreibungsverordnung (AMVV), which governs the prescription of medicinal products in Germany. Issued by the Federal Ministry of Health on 9 October 2025, the document is primarily technical in nature and focuses on updates to the list of prescription-only medicines and related administrative provisions. The regulation ensures continued alignment with EU pharmacovigilance standards and domestic health policy objectives regarding controlled dispensing of pharmaceuticals.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Updates the list of prescription-only medicinal products (verschreibungspflichtige Arzneimittel)
- Adjusts certain administrative requirements for issuing prescriptions in pharmacies
- Incorporates technical changes to align with current EU pharmaceutical legislation
+ 2 more changes with Pro